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Abstract
Background: Lyme neuroborreliosis (LNB), caused by the spirochete Borrelia burgdorferi, affects both the peripheral
and the central nervous systems. Radiculitis or nerve root inflammation, which can cause pain, sensory loss, and
weakness, is the most common manifestation of peripheral LNB in humans. We previously reported that rhesus
monkeys infected with B. burgdorferi develop radiculitis as well as inflammation in the dorsal root ganglia (DRG),
with elevated levels of neuronal and satellite glial cell apoptosis in the DRG. We hypothesized that B. burgdorferi
induces inflammatory mediators in glial and neuronal cells and that this inflammatory milieu precipitates glial and
neuronal apoptosis.
Methods: To model peripheral neuropathy in LNB we incubated normal rhesus DRG tissue explants with live
B. burgdorferi ex vivo and identified immune mediators, producer cells, and verified the presence of B. burgdorferi in
tissue sections by immunofluorescence staining and confocal microscopy. We also set up primary cultures of DRG
cells from normal adult rhesus macaques and incubated the cultures with live B. burgdorferi. Culture supernatants
were subjected to multiplex ELISA to detect immune mediators, while the cells were evaluated for apoptosis by the
in situ TUNEL assay. A role for inflammation in mediating apoptosis was assessed by evaluating the above
phenomena in the presence and absence of various concentrations of the anti-inflammatory drug dexamethasone.
As Schwann cells ensheath the dorsal roots of the DRG, we evaluated the potential of live B. burgdorferi to induce
inflammatory mediators in human Schwann cell (HSC) cultures.
Results: Rhesus DRG tissue explants exposed to live B. burgdorferi showed localization of CCL2 and IL-6 in sensory
neurons, satellite glial cells and Schwann cells while IL-8 was seen in satellite glial cells and Schwann cells. Live B.
burgdorferi induced elevated levels of IL-6, IL-8 and CCL2 in HSC and DRG cultures and apoptosis of sensory
neurons. Dexamethasone reduced the levels of immune mediators and neuronal apoptosis in a dose dependent
manner.
Conclusion: In this model, B. burgdorferi induced an inflammatory response and neuronal apoptosis of DRG. These
pathophysiological processes could contribute to peripheral neuropathy in LNB.
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Background
Lyme neuroborreliosis (LNB), the form of Lyme disease
that affects the nervous system, is manifest in about 15%
of patients. Both the central and peripheral nervous
systems may be affected [1-5]. Patients with central ner-
vous system (CNS) involvement may complain of head-
ache, flu-like symptoms, fatigue, memory loss, learning
disability or depression. Infection of the peripheral ner-
vous system (PNS) with Borrelia burgdorferi, the Lyme
disease bacterium, may result in facial nerve palsy, pain,
sensory loss, or muscle weakness.
Clinically, LNB may manifest as meningitis, typically
characterized by lymphocytic pleocytosis in the cerebro-
spinal fluid (CSF), meningoradiculitis (also known as
Bannwarth’s syndrome), cranial neuritis, encephalopathy,
peripheral neuropathy and, less commonly, encephalitis
and encephalomyelitis. Radiculitis, or inflammation in
the dorsal roots, is the most common manifestation of
untreated LNB in humans [2,4]. LNB patients may also
experience a wide array of neurological symptoms as a
result of white matter inflammation in the brain and
spinal cord that results in a sub-acute multiple sclerosis
(MS)-like manifestation [6,7].
Pathology reports from human cases of LNB have de-
scribed lymphocyte and plasma cell infiltration in the
meninges and perivascularly in the nerve roots, dorsal
root ganglia (DRG), as well as demyelination in the brain
and spinal cord [8-13]. Typically, peripheral nervous sys-
tem Lyme disease is associated with patchy multifocal
axonal loss with epineural perivascular inflammatory in-
filtrates or perineuritis [14-18].
In an earlier study, histopathological evaluation showed
varying degrees of necrosis in the sensory ganglia of rhesus
macaques that were infected with B. burgdorferi, in
addition to positive immunostaining with monoclonal
antibodies against a 7.5 kDa lipoprotein of B. burgdorferi
[19]. In an in vivo experiment in which we inoculated B.
burgdorferi into the cisterna magna of rhesus macaques,
analysis of the CSF within one-week post-inoculation
showed increased levels of IL-6, IL-8, CCL2, and CXCL13,
accompanied by a monocytic/lymphocytic pleocytosis.
This inflammatory response was concomitant with histo-
pathological changes consistent with acute neurologic
Lyme disease, such as leptomeningitis and radiculitis. In
addition, we observed elevated levels of neuronal and sat-
ellite glial cell apoptosis in the DRG of infected animals as
compared to uninfected controls and documented the
presence of IL-6 in DRG neurons of infected animals [20].
The mechanisms underlying the pathogenesis of per-
ipheral LNB are not clearly understood. Based on our
observations, we hypothesized that B. burgdorferi was
able to induce inflammatory mediators in glial and neur-
onal cells and that this inflammatory context precipi-
tated glial and neuronal apoptosis. As a model to study
the mechanisms underlying peripheral neuropathy seen
in patients with Lyme neuroborreliosis, we obtained
fresh rhesus DRG tissue explants and allowed live Lyme
disease bacteria to interact with the tissue explants
ex vivo to allow for accumulation of intracytoplasmic
proteins. Cryo-sections were stained to detect immune
mediators, the phenotypes of producer cells and the
presence of B. burgdorferi spirochetes, and were visual-
ized using confocal microscopy. We also set up primary
cultures of dorsal root ganglia cells from normal adult
rhesus macaques and characterized the cells phenotypic-
ally. We then incubated the DRG cultures with live B.
burgdorferi. Culture supernatants were used for the de-
tection of immune mediators while the cells were
assessed for apoptosis. To determine if inflammation
had a role in apoptosis, the above phenomena were eval-
uated in the presence and absence of various concentra-
tions of the anti-inflammatory drug dexamethasone.
Since DRG also contain Schwann cells, which ensheath
the dorsal roots, we investigated whether B. burgdorferi
had the potential to induce inflammation in human
Schwann cells. The results of these experiments are de-
scribed below.
Methods
Growth and preparation of live spirochetes
B. burgdorferi B31 clone 5A19 spirochetes, passage 1 to
3 were grown to late logarithmic phase under micro-
aerophilic conditions in Barbour Stoenner-Kelly (BSK)
medium, supplemented with 6% rabbit serum (Sigma, St.
Louis, MO, USA) and antibiotics (rifampicin at 45.4 mg/
mL, fosfomycin at 193 mg/mL and amphotericin at
0.25 mg/mL). Spirochetes were pelleted at 2000 × g for
30 minutes at room temperature. At the end of the run
the rotor was left to coast without breaking so as to
minimize damage to the live spirochetes. The culture
was washed using sterile phosphate buffered saline (PBS)
and resuspended in the working medium at the desired
density.
Incubation of dorsal root ganglia explant slices with live
spirochetes
DRG tissue was obtained immediately after euthanasia
from three normal rhesus macaques and placed in PBS
pH 7.2 (Invitrogen, Grand Island, NY, USA) at room
temperature. The tissue was sliced using sterile number
21 scalpels (Personna Medical, Verona, VA, USA). The
slices were placed in separate wells of 12-well plates
(Fisher Scientific, Fair Lawn, NJ, USA), each containing
2 ml of RPMI 1640 medium (Invitrogen) supplemented
with 10% fetal bovine serum (FBS) (Invitrogen). Live B.
burgdorferi spirochetes at a final density of 1 × 107/mL
were added to some wells. Some wells received, in
addition, brefeldin A (Molecular Probes, Eugene, OR,
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USA), a fungal metabolite that blocks protein transport
[21] at a final concentration of 10 μg/mL. Corresponding
control slices were also held in medium plus brefeldin A
without spirochetes. The DRG slices were then incu-
bated at 37°C for four hours in a humidified 5%-CO2 in-
cubator. At the end of the four-hour incubation, tissue
slices were fixed in 2% paraformaldehyde in PBS pH 7.0
(USB, Cleveland, OH, USA) and cryopreserved as de-
scribed earlier [22].
Immunofluorescence staining for detection of
intracytoplasmic immune mediators
For in situ analysis of intracytoplasmic proteins, frozen
tissue blocks were cryosectioned into 16-μm sections as
previously described [22]. A total of ten cryosections
was evaluated per tissue block from each of the above
three animals for detection of intracytoplasmic immune
mediators. DRG tissue slices were subjected to im-
munofluorescence staining as previously described [23].
The primary antibodies against various phenotypic mar-
kers of cells used were anti-human neurotrophin recep-
tor p75 (p75NTR) polyclonal rabbit antibody presented
in rabbit serum used at 1:10 dilution (Millipore, Billerica,
MA, USA), anti-human 2′,3′-cyclic nucleotide 3′-phos-
phodiesterase (CNPase), clone 11-5B mouse IgG1
(Millipore) at 10 μg/mL, anti-human S-100 (Sigma) at
1:500, anti-human neuronal protein NeuN, MAB 377
clone A60, mouse IgG1 (Millipore) at 1:10, or anti-
human glial fibrillary acidic protein (GFAP), at 1:200,
clone G-A-5 purified mouse immunoglobulin conjugated
to Cy3 (Sigma). Primary antibodies for immune media-
tors were either anti-human IL-6, mouse IgG2a at
1:1000 (ProSpec, Ness Ziona, Israel), anti-human CCL2,
mouse IgG1 (5 J): SC-32771 at 1:50 (Santa Cruz Biotech-
nology, Santa Cruz, CA, USA) or rabbit polyclonal IgG
clone ab7814 at 1:50 (AbCam, Cambridge, MA, USA),
anti-human IL-8 polyclonal rabbit IgG at 10 μg/mL
(RDI, Flanders, NJ, USA). B. burgdorferi was stained with
a polyclonal rabbit antibody against whole Borrelia at
1:200 (Accurate Chemicals, Westbury, NY, USA) in
combination with a Zenon kit Alexa 647 (Invitrogen).
Isotype controls (Sigma) at the concentrations of the re-
spective primary monoclonal antibodies and universal
rabbit negative control (Dako Cytomation, Carpinteria,
CA, USA) for rabbit polyclonals were also included. All
primary antibodies and isotype controls at the appropri-
ate concentrations were prepared in PBS containing 10%
normal goat serum (NGS, Invitrogen), 0.2% fish skin gel-
atin (FSG, Sigma) and 0.02% sodium azide (Sigma), and
left on the slides for one hour at room temperature in a
humidifying chamber. The slides were then washed with
PBS-FT buffer (PBS pH 7.4 containing 0.2% FSG and
0.02% Triton X-100 (MP Biomedicals, Solon, OH, USA)
and then held in this buffer for five minutes followed by a
rinse with PBS-F buffer (phosphate-buffered saline
containing 0.2% FSG).
The relevant secondary antibodies, goat anti-rabbit con-
jugated to one of the Alexa fluorochromes, Alexa 488
(green), 568 (red) or 633 (blue) (Invitrogen), at a dilution
of 1:1000 in PBS containing 10% NGS, 0.2% FSG and
0.02% sodium azide were applied to the tissues and left in
the humidified dark slide chamber at room temperature
for 30 to 45 minutes. In some cases the Zenon Rabbit IgG
labeling kit was used (Invitrogen). Slides were washed with
PBS-FT buffer and rinsed with PBS-F buffer as described
above and then mounted in anti-quenching medium
(Sigma). The stained and mounted slides were stored in
the dark at 4°C until they were viewed.
Rhesus primary dorsal root ganglia cultures
Chamber slides (two wells) with detachable culture
slides that were previously coated with poly-D lysine
(BD Biosciences, Franklin Lakes, NJ, USA) were coated
with mouse laminin (Invitrogen) at a final concentration
of 10 μg/mL for a minimum of two hours before seeding
the cells. Just before plating the DRG cells, the laminin
was removed and wells were rinsed twice with sterile
deionized water. Cells were seeded immediately after
removal of the laminin. DRG from two adult rhesus
monkeys were obtained at necropsy and transported im-
mediately on ice in high glucose (D)MEM F12 (Invitrogen)
containing penicillin and streptomycin (P/S) (1 × of
10,000 units of penicillin and 10,000 μg/mL of strepto-
mycin) (Invitrogen) to the biosafety chamber. The DRG
were transferred to a petri dish containing Hanks balanced
salt solution (HBSS) (Invitrogen). The nerve trunks were
cut away using sterile number 21 scalpel blades (Personna
Medical). The tissue from about four to six DRG from
each animal was minced and transferred to a tube
containing 5 mL of 0.25% trypsin ethylenediaminete
traacetic acid (EDTA) (Invitrogen) with 1,000 units of
DNAse (Sigma). The minced tissue was transferred to a
water bath set at 37°C for 10 to 15 minutes with intermit-
tent shaking. The trypsinization was stopped by adding
25 mL of complete (D)MEM medium containing 10% FBS
(Fisher Scientific) and P/S. The complete cell suspension
was centrifuged at 1800 to 2000 rpm (300 to 350 g) for
ten minutes at room temperature (18°C). The cell pellet
was transferred to a clean tube containing 5 mL of
complete (D)MEM F12, supplemented with NGF-7S
(Invitrogen) at a concentration of 50 ng/mL. (D)MEM was
supplemented with fresh L-glutamine at a final concentra-
tion of 2 mM. The cells were counted using a hemo-
cytometer and resuspended to a final count of 2 × 105/mL.
Cells were seeded at a count of 1 × 105 cells per well, by
seeding 500 μl of the above suspension per well. Chambers
were left in the humidified CO2 incubator for one hour,
after which a volume of 1.5 mL of complete (D)MEM F12
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medium containing 10% FBS and P/S supplemented with
fresh L-glutamine (2 mM), and NGF (50 ng/mL) was
added gently to each well drop by drop and left to incu-
bate. Cultures were maintained for a period of six to seven
days with medium changes every three to four days. The
DRG culture protocol was adapted from previously pub-
lished protocols for the isolation of DRG neurons from
embryonic or adult rats, [24].
Human Schwann cell cultures
Cryopreserved human Schwann cell (HSC) cultures
obtained from ScienCell Inc., (Carlsbad, CA, USA), (iso-
lated from adult human spinal nerves) were revived in
tissue culture flasks coated with poly-L-lysine as per the
manufacturer’s instructions and maintained in the sup-
plied Schwann cell medium (SCM) consisting of basal
medium, 5% FBS, 1% Schwann cell growth supplement
and 1 x antibiotic mixture of penicillin/streptomycin.
Several aliquots of the above-revived culture (passage
two) were frozen back as per the manufacturer’s instruc-
tions and thawed and revived as needed for experiments.
Cultures that were 80% confluent were trypsinized and
re-seeded onto poly-L-lysine chamber slides containing
two wells at a seeding density of 1 × 104 cells per well,
as recommended by ScienCell Inc., after which they
were maintained in SCM for three days prior to com-
mencing experiments. Extra wells were seeded to evalu-
ate final cell count prior to incubation with live B. burg
dorferi at the desired multiplicity of infection (MOI).
Duplicate wells were seeded for each condition for each
of the two experiments, set up using different passage-
two stocks. Both basal media and Schwann cell sup-
plement were supplied by the manufacturer and their
composition is proprietary. HSC maintained on poly-L-
lysine-coated chamber slides were used for the eva-
luation of phenotypic markers and secreted immune
mediators using a Human 23-plex Cytokine-Chemokine
Array kit (Millipore) described below.
Immunofluorescence staining and confocal microscopy
for detection of the expression of Schwann cell, neuronal
and satellite glial cell markers
Medium was removed from HSC cultures or DRG cul-
tures and cells were fixed in 2% paraformaldehyde (PFA)
followed by post-fixation permeabilization using a mix-
ture of ethanol:acetic acid (2:1) (Sigma) for five minutes
at −20°C. The slides were then detached from the cham-
ber and processed for immunofluorescence staining as
previously described [25].
Schwann cell cultures were evaluated for the expression
of myelin basic protein (MBP), using rabbit polyclonal
anti-human MBP Clone AB 980 at 1:100 (Millipore,
Billerica, MA, USA), and CD-90 using mouse monoclonal
IgG1 anti-human THY-1 (CD90) at 10 μg/mL (Millipore),
in addition to CNPase, p75 NTR and S-100, while DRG
cultures were evaluated for the expression of NeuN, GFAP,
S-100, CNPase and p75 NTR, as described above in the
section entitled ‘Immunofluorescence staining for detec-
tion of intracytoplasmic immune mediators’.
Confocal microscopy was performed using a Leica TCS
SP2 confocal microscope equipped with three lasers (Leica
Microsystems, Exton, PA, USA). Images of individual chan-
nels were merged to obtain images containing all channels.
Photoshop CS3 (Adobe Systems Inc., San Jose, CA, USA)
was used to assign colors to each fluorochrome.
Evaluation of the role of inflammation in mediating
neuronal apoptosis in dorsal root ganglia cultures using
the anti-inflammatory drug dexamethasone
DRG cell cultures were seeded as described above in
chamber slides for evaluation of apoptosis or for evalu-
ation of immune mediators and maintained in growth
medium for six days. Prior to stimulation with live B.
burgdorferi, DRG cultures were incubated with various
concentrations of dexamethasone (water soluble), 5 μM,
15 μM and 150 μM (Sigma) for 24 hours at 37°C, after
which they were washed and then incubated in fresh
growth medium containing the respective concentra-
tions of dexamethasone and live B. burgdorferi at a MOI
of 10:1 at 37°C for 24 hours and devoid of P/S. Similar
concentrations of dexamethasone as those mentioned
above have been reported to inhibit the production of
CCL2 in mice microglia [26]. The dexamethasone that
we used in our experiments is supplied as a water-soluble
formulation consisting of dexamethasone and a carrier
substance (2-hydroxypropyl)-β-cyclodextrin (HPC). The
effect of HPC alone, at respective molar concentrations
found in the concentrations of dexamethasone that we
used in our experiments, was done by incubating DRG
cultures as described above in the presence and absence of
B. burgdorferi and the above mentioned concentrations of
carrier alone at 15 μM, 45 μM and 450 μM, respectively.
After 24 hours, culture supernatants were collected
and processed for quantification of inflammatory media-
tors, and cells were fixed and evaluated for apoptosis by
the in situ terminal deoxynucleotidyl transferase medi-
ated UTP nick end labeling (TUNEL) assay as described
below. Medium controls that were pretreated and then
incubated with the same respective concentrations of
dexamethasone but without the addition of live B.
burgdorferi were also included.
Evaluation of apoptosis by in situ TUNEL assay
Cells contained in chamber slides were labeled for NeuN
by immunofluorescence staining as described above. Slides
were then fixed with 2% PFA, washed three times with PBS
by rinsing the slides in PBS and holding them in PBS for
two minutes between washes. Slides were then subjected
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to the TUNEL-ApopTagPlus fluorescein in situ apop-
tosis assay (Chemicon, Temecula, CA, USA) as per the
manufacturer’s instructions. Slides were then mounted
as described above and stored at 4°C in the dark until
viewed. The percentage of apoptotic neurons from ten
fields was evaluated from each chamber area by coun-
ting the total number of NeuN-positive cells (at least
500 cells) from each of the chamber areas, followed by
the percentage of cells that showed co-localization of
both the TUNEL signal and NeuN expression. All
counts were made by viewing slides under a fixed
magnification of 63X (corresponding to an area of
0.05 mm2) using the confocal microscope. Cultures
were also stained with S-100 prior to doing the TUNEL
assay as described above to detect apoptotic satellite
glial cells.
Stimulation of human Schwann cell cultures with live
B. burgdorferi for evaluation of immune mediators
B. burgdorferi strain B31 5A19 passage 3 was prepared as
described above. The HSC cultures were washed in SCM
devoid of P/S. The B. burgdorferi culture was resuspended
in SCM devoid of P/S, at the desired MOI. Controls with
no spirochetes were also included. Cultures were incu-
bated for 48 hours in a humidified 5% CO2 incubator set
at 37°C. At the 48-hour time point culture supernatants
were collected for evaluation of inflammatory mediators.
Culture supernatants were centrifuged at 4°C at 2000 × g
to remove any suspended bacteria and the supernatant
was aliquoted and stored at −70°C until used.
Evaluation of immune mediators from culture
supernatants
The concentrations of cytokines and chemokines present
in the culture supernatants from rhesus DRG were
quantified using the MILLIPLEX MAP Non-Human
Primate Cytokine Magnetic Bead Panel - Premixed 23
Plex, PCYTMG-40 K-PX23 Cytokine-Chemokine Array
kit (Millipore) following the manufacturer’s instructions.
The analytes detected by this panel are: G-CSF, GM-CSF,
IFN-γ, IL-10, IL-12/23 (p40), IL-13, IL-15, IL-17, IL-18,
IL-1ra, IL-1β, IL-2, IL-4, IL-5, IL-6, IL-8, CCL2, CCL3,
CCL4, TGF-α, TNF-α, VEGF and sCD40L. The concentra-
tions of cytokines and chemokines present in the culture
supernatants from HSC cultures described above were
quantified using the MILLIPLEX Human Cytokine/
Chemokine - Premixed 14 Plex, MPXHCYTO60KP
MX14 Cytokine-Chemokine Array kit (Millipore) fol-
lowing the manufacturer’s instructions. The analytes
detected by this panel are: GM-CSF, IFN-γ, IL-10, IL-12
(p70), IL-13, IL-1β, IL-2, IL-4, IL-5, IL-6, IL-7, IL-8, CCL2
and TNF-α. The multiplex plate was read using a Bio-Plex
200 Suspension Array Luminex System (Bio-Rad, Hercules,
CA, USA).
Statistical evaluation
The unpaired-two tailed t test was used to evaluate the
statistical significance between means of data sets, using
Graphpad Prizm software (Graph Pad Software Inc.) ver-
sion 4. A P value of 0.05 or lower was considered to be
statistically significant.
Results
Visualization of CCL2, IL-6 and IL-8 in cells from dorsal
root ganglia tissue explants after ex vivo stimulation with
live spirochetes
The DRG tissue explants stimulated ex vivo with spiro-
chetes in the presence of brefeldin A showed localization
of CCL-2 in sensory neurons (Figure 1A). CCL-2, which
is stained green in this tissue, is localized inside the neu-
rons giving a yellow signal due to the co-localization of
red and green within the neurons. CCL-2 is also seen in
areas occupied by satellite glial cells and dorsal root in
the DRG. CCL-2 in green is seen co-localizing with the
satellite glial cell marker GFAP (Figure 1B). Both satellite
glial cells and sensory neurons in the DRG that are
known to stain positive for S-100 [27], seen in red, show
the presence of CCL-2 (Figure 1C). CCL-2 is also seen
to co-localize with Schwann cells in the dorsal root,
staining positive with p75NTR, seen in red (Figure 1D),
while remaining unstained nerve tissue is seen as gray.
The spirochetes appear blue in Figure 1A-1D.
Similarly, the cytokine IL-6 was seen to be localized in
sensory neurons (Figure 1E and Figure 1F, respectively)
and in satellite glial cells (Figure 1F). Schwann cells also
showed the presence of IL-6 (Figure 1G).
The chemokine IL-8 was localized inside satellite glial
cells (Figure 1H) and in Schwann cells (Figure 1I) but
not in neurons. The lack of IL-8 production in neurons
was confirmed by staining the section for detection of
IL-8 and with NeuN, a specific marker for neurons (not
shown). CCL2, IL-6 and IL-8 were not detected in con-
trol sections of DRG explants that were held in medium
containing brefeldin A for four hours in the absence of
B. burgdorferi. Representative images showing the ab-
sence of CCL-2, IL-6 and IL-8 (green signal) in control
sections (no B. burgdorferi) that were also stained in par-
allel for S-100, CNPase or NeuN (all appearing red) are
shown in Figure 1J, Figure 1K, and Figure 1L, respect-
ively. The unstained tissue appears gray. No signal was
detected in sections stained with isotype controls for re-
spective primary antibodies followed by corresponding
secondary antibodies for the mediators or the cell
markers (not shown).
Phenotypic cell markers expressed in primary cultures of
dorsal root ganglia cells
In order to permit a more detailed evaluation of the abil-
ity of B. burgdorferi spirochetes to elicit inflammation
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Figure 1 Visualization of CCL2, IL-6, IL-8 and B. burgdorferi. (A) CCL-2 (green) inside neurons stained red with NeuN. The signal for CCL-2 is
also in satellite glia and dorsal root nerves. (B) CCL-2 in green in satellite glia stained red with GFAP-cy3. (C) CCL-2 in green in satellite glial and
neurons stained red with S-100. CCL-2 also co-localizes with Schwann cells staining positive with p75NTR, in red in the dorsal root (D). Unstained
nerve tissue is gray as imaged by differential interference contrast (DIC). The spirochetes in A-D appear blue stained with antibody against whole
B. burgdorferi, in combination with a Zenon labeling Kit Alexa 647. (E) IL-6 (green) localized inside neurons staining red with NeuN. The signal for
IL-6 is also in areas occupied by satellite glia. (F) IL-6 in green within the satellite glia and neurons stained red by S-100. The signal for IL-6 is also
seen in areas occupied by sensory neurons. (G) IL-6 (green) in Schwann cells stained with p75NTR, in red in the dorsal root; the remaining
unstained nerve tissue is gray as imaged by DIC. The spirochetes appear blue in E-G. (H) IL-8 (green) inside satellite glia stained positive for GFAP
(red). The signal for IL-8 is not seen in areas occupied by neurons. (I) IL-8 (green) co-localized within Schwann cells stained with CNPase (red) in
the dorsal root. Spirochetes appear blue in H and I. (J, K and L) show the absence of CCL2 , IL-6 and IL-8, respectively, in control sections (green
signal) that were also stained in parallel for S-100, CNPase or NeuN (all appearing red). The unstained tissue appears gray as imaged by DIC.
Results indicate representative images of DRG explants from three adult rhesus macaques. CNPase, 2′,3′-cyclic nucleotide 3′-phosphodiesterase;
DRG, dorsal root ganglia; GFAP, glial fibrillary acid protein.
Ramesh et al. Journal of Neuroinflammation 2013, 10:88 Page 6 of 14
http://www.jneuroinflammation.com/content/10/1/88
and apoptosis in DRG cells, we set up in vitro cultures
of these cells and characterized their phenotypes. The
primary rhesus DRG cultures consisted primarily of a
mat of sensory neurons that stained positive for the
neuronal marker NeuN and a few stray satellite glial
cells that stained positive for the glial cell marker S-100
(Figure 2A). The satellite glial cells also showed the ex-
pression of GFAP (Figure 2B). The sensory neurons in
the DRG cultures did not stain positive for S-100, con-
trary to what we had observed in sensory neurons within
DRG tissue explants (Figure 1C and Figure 1F). The nu-
clei of all cells in Figure 2A and 2B appeared blue due to
staining with the nuclear stain TOPRO3. DRG culture
slides that were incubated with respective isotype con-
trols of primary antibodies and corresponding secondary
antibodies did not show any detectable signal (not
shown). DRG cultures did not show specific staining
with antibodies to the Schwann cell markers CNPase or
p75NTR.
Expression of MBP, CNPase and p75NTR in human
Schwann cell cultures
As we were not able to detect the presence of Schwann
cells in the DRG cultures described above, we resorted to
cultivating commercially available HSCs and confirmed
their phenotype and purity. HSC cultures showed specific
staining with MBP and did not show the expression of
CD-90 (Figure 3A). Our HSC cultures also showed the ex-
pression of the myelinating marker CNPase and the
Schwann cell marker p75NTR (Figure 3B). The HSC cul-
tures did not show any signal when stained with isotype
controls for the various primary antibodies at the relevant
concentrations followed by secondary antibodies. A
representative image of HSC cultures stained with isotype
control for mouse IgG1 followed by goat anti-mouse
Alexa Fluor 568 is shown in Figure 3C. The nuclei of cells
appear blue in Figure 3A, 3B and 3C due to staining with
the nuclear stain TOPRO3. The HSC expressed the
markers known to be present on adult HSCs, such as
MBP [28], CNPase [29] and p75 NTR [30] but did not
show the expression of CD90/THY-1, a phenotypic
marker of perineural fibroblasts [31], thus signifying the
purity of the HSC culture.
Effect of dexamethasone on the pro-inflammatory
response elicited by B. burgdorferi in primary rhesus
dorsal root ganglia cultures
Live B. burgdorferi spirochetes incubated with rhesus
DRG cultures for 24 hours at a MOI of 10:1 induced
significantly elevated levels of CCL2 (Figure 4A), IL-6
(Figure 4B) and IL-8 (Figure 4C) compared to the levels
induced in medium controls. The concentration of
CCL2 surpassed 20,000 pg/mL, whereas the constitutive
level of this chemokine that was produced in medium
alone was around 8,000 pg/mL (Figure 4A). The basal
concentration of IL-6 was 4,000 pg/mL but reached al-
most 8,000 pg/mL (Figure 4B) and the basal level of IL-8
production in DRG cultures was around 800 pg/mL but
reached about 5,000 pg/mL when stimulated with live
B. burgdorferi for 24 hours (Figure 4C).
Dexamethasone significantly reduced the levels of CCL2
(P <0.01), IL-6 (P <0.05) and IL-8 (P <0.05) as induced by
live B. burgdorferi (MOI of 10:1) in DRG cultures after
24 hours in a dose dependent manner as shown in
Figures 4A, 4B and 4C, respectively. We confirmed that the
anti-inflammatory effect of the dexamethasone formulation
Figure 2 Expression of the neuronal marker NeuN and satellite glial cell markers GFAP and S-100 in primary rhesus DRG cultures.
Primary rhesus DRG cultures showing a mat of sensory neurons staining positive for the neuronal marker NeuN (red) (A) and a few stray satellite
glial cells staining positive for the glial cell markers S-100 and GFAP (B). The nuclei of all cells in A and B appear blue due to staining with the
nuclear stain TOPRO3. DRG, dorsal root ganglia; GFAP, glial fibrillary acid protein.
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was due to its dexamethasone fraction and not due to the
carrier substance (HPC), as HPC alone at 15 μM, 45 μM
and 450 μM present in the dexamethasone solutions at the
concentrations used above was unable to reduce the levels
of B. burgdorferi-induced immune mediators (Figure 4A,
4B and 4C, respectively). Data represent mean values and
standard deviations between values of two independent
experiments.
Inhibiting effect of dexamethasone on apoptosis induced
by B. burgdorferi in primary rhesus dorsal root ganglia
cultures
Live B. burgdorferi induced elevated levels of apoptosis
of sensory neurons, as detected by the in situ TUNEL
assay in primary rhesus DRG cultures, after 24 hours of
incubation. Apoptosis visualized by confocal microscopy
in cells that were held in medium alone is shown in
Figure 5A, after incubation with live B. burgdorferi at
MOI of 10:1 in Figure 5B and with B. burgdorferi plus
dexamethasone at 15 μM in Figure 5C, respectively. The
sensory neurons appear red due to staining with the
neuronal marker NeuN. The TUNEL signal can be visu-
alized in green while the nuclei of all cells appear blue due
to staining with the nuclear stain TOPRO3. Figure 5D
shows percent apoptosis as measured by the in situ
TUNEL assay after 24 hours of incubation of DRG cul-
tures in medium (2.41% ± 0.62), B. burgdorferi alone at a
MOI of 10:1 (13.82% ± 1.39) and B. burgdorferi + dexa-
methasone at 5 μM, 15 μM and 150 μM in medium.
Dexamethasone induced a significant reduction in B.
burgdorferi-dependent apoptosis at 15 μM (7.39 ± 0.74)
and 150 μM (5.32 ± 0.84) (P <0.05), respectively. The
mean percent apoptosis and standard deviations quanti-
fied from ten microscope fields (a total of 500 cells) for
each condition is shown in Figure 5D. The results repre-
sent the mean and standard deviation of values obtained
from two independent experiments. No apoptosis was
seen in the satellite glial cells in the primary rhesus DRG
cultures, (not shown).
Pro-inflammatory response induced by B. burgdorferi in
HSC cultures
As we had detected the presence of CCL2, IL-6 and IL-
8 in the dorsal roots of the DRG explants stimulated
ex vivo with live B. burgdorferi, we evaluated the
potential of live spirochetes to induce inflammatory
mediators in in vitro cultures of pure HSC. Live B.
burgdorferi spirochetes incubated with HSC cultures
for 48 hours at a MOI of 10:1 and 50:1 induced signifi-
cantly elevated levels of CCL2 (Figure 6A), IL-6
(Figure 6B) and IL-8 (Figure 6C) as compared to the
levels induced in medium controls. The concentration
of CCL2 surpassed 21,000 pg/mL and 32,000 pg/mL at
a MOI of 10:1 and 50:1, respectively, whereas the con-
stitutive level of this chemokine was about 13,000 pg/
mL (Figure 6A). The basal concentration of IL-6 was
only about 300 pg/mL but reached more than 1,150 pg/
mL and 2,500 pg/mL at a MOI of 10:1 and 50:1, re-
spectively (Figure 6B). Similarly, the basal concentra-
tion of IL-8 that was around 6,400 pg/mL reached
more than 16,000 pg/mL and 23,000 pg/mL at a MOI
of 10:1 and 50:1, respectively (Figure 6C). Data repre-
sent mean values and standard deviations between
values of two independent experiments.
Discussion
The pathogenesis of Lyme disease neuropathies is poorly
understood. B. burgdorferi infection may damage neural
cells by the direct action of spirochetes or spirochetal
products on glial and neuronal cells. It is also possible
that spirochetes induce cytotoxic or inflammatory medi-
ators locally in glial, neuronal or endothelial cells and,
thus, cause indirect damage. Infiltrating immune cells
and/or the presence of cross-reactive antibodies to self-
Figure 3 Expression of MBP, CNPase and p75NTR in HSC cultures. (A) shows HSC cultures staining with MBP (red) but not CD-90. (B) shows
the expression of the myelinating marker CNPase (red) and the Schwann cell marker p75NTR (green) in HSC cultures. A representative image of
HSC cultures stained with isotype control for mouse IgG1 followed by goat anti-mouse Alexa Fluor 568 is shown in (C). The nuclei of cells appear
blue in A, B and C due to staining with nuclear stain TOPRO3. CNPase, 2′,3′-cyclic nucleotide 3′-phosphodiesterase; HSC, human Schwann cell;
MBP, myelin basic protein.
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antigens at the site of infection/inflammation may also
be deleterious to neural cells.
Neuronal proteins, anti-myelin antibodies and cells se-
creting antibodies to MBP have been detected in the CSF
of patients with LNB, indicating possible glial and neur-
onal damage [32,33]. The antigenic determinants on the
41 kDa flagellar protein of B. burgdorferi are shared by
several human tissue components such as Schwann cells
from the PNS [34]. Long-term murine intrathecal expos-
ure to a lipoprotein of B. burgdorferi, outer-surface protein
C, resulted in axonal damage. Intrathecal exposure to B.
burgdorferi lipoproteins may be one of the causes of the
neurologic manifestations of Lyme disease [35]. The in-
volvement of sensory ganglia in human LNB has also been
previously documented [15,36]. One rare peripheral ner-
vous system manifestation of LNB is the Guillain-Barré-
like syndrome, a prototype of immune-mediated periph-
eral neuropathies where neither the initial event nor the
antigen that triggers the immune reaction is known. Auto-
immune mechanisms similar to those suggested in MS
have also been implied in the pathogenesis of central ner-
vous system LNB [37].
Our earlier findings in the rhesus model of peripheral
LNB of both the early disseminated and chronic phases in
the PNS mirror several aspects of these forms of the dis-
ease in humans [38,39]. The primary findings of axonal
degeneration and regeneration, and multifocal nerve le-
sions showing perivascular inflammatory cellular infil-
trates have been documented in almost all patients with
Lyme-associated peripheral neuropathy [15,16,40-42]. The
results of these studies suggest that immune mediated
neuronal and glial cell damage could be involved in the
neuropathy of LNB.
Cytokines and chemokines are key immune mediators
that play an important role in promoting CNS injury in
various kinds of inflammatory neurodegenerative diseases
[43-47]. Importantly, various inflammatory cytokines and
chemokines have also been reported in the CSF of patients
with LNB [48-51]. The potential of B. burgdorferi to in-
duce cytokines, chemokines and other inflammatory
mediators in glial and neuronal cells as well as glial
and neuronal apoptosis has been well documented
[20,23,25,52-56].
In this study we explored the potential of the Lyme
disease bacteria to cause inflammation in tissue explants
of rhesus DRG, as well as in primary cultures of rhesus
DRG cells and human Schwann cells, as a representation
of the Schwann cells that ensheath the dorsal roots. Pri-
mary cultures of DRG cells from rhesus monkeys may
prove useful in understanding the mechanisms involved
in Lyme peripheral neuropathy, as well as in other hu-
man peripheral neuropathies [57].
We documented the ability of B. burgdorferi to elicit
the production of IL-6, IL-8, and CCL2 in cells of the
DRG and to induce the death of sensory neurons in
DRG cell cultures. The ability of sensory neurons of the
DRG to express CCL2 has also been documented in pain
models [58]. Our in vitro DRG culture did not favor the
Figure 4 Effect of dexamethasone on the pro-inflammatory
response elicited by B. burgdorferi in primary rhesus DRG
cultures. The levels of CCL2 (A), IL-6 (B) and IL-8 (C), respectively, in
rhesus DRG cultures stimulated with live B. burgdorferi spirochetes
for 24 hours at a MOI of 10:1 and in medium controls (* P <0.05,
** P <0.01) in the presence and absence of dexamethasone and
carrier HPC are shown. Data represent mean values and standard
deviations between values of duplicate wells that were seeded from
DRG cells that were isolated from two adult rhesus macaques. DRG,
dorsal root ganglia; HPC, (2-hydroxypropyl)-β-cyclodextrin; MOI,
multiplicity of infection.
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growth of Schwann cells, which are known to ensheath
the dorsal root axons in the DRG, possibly because the
culture medium was tailored to supporting the neurons.
Interestingly, the few satellite glial cells that were present
in our DRG cultures did not undergo apoptosis in re-
sponse to B. burgdorferi. We had previously observed
the apoptosis of satellite glial cells in DRG of rhesus
monkeys infected intrathecally with live B. burgdorferi
[20]. It is possible that there are additional regulatory
factors that come into play in the in vivo environment
that are absent in the in vitro culture system. Specific-
ally, this difference may have been brought about by the
absence of Schwann cells in the DRG cultures, especially
considering their documented contribution to inflamma-
tion in response to B. burgdorferi.
Using rhesus DRG tissue explants we identified the
phenotypes of the producer cells as satellite glial cells by
the expression of glial markers such as S-100 [59,60]
and GFAP. Like other glial cells, the satellite glial cells
are known to respond to nerve injury by up-regulating
GFAP [61]. We identified Schwann cells in rhesus DRG
tissue explants by the expression of p75NTR and
CNPase [29,30,62]. These cells, in addition to DRG sat-
ellite cells, produced IL-6, IL-8 and CCL2, while neu-
rons, which were characterized by the expression of
NeuN [63], produced IL-6 and CCL2 but not IL-8. The
Figure 5 Protective effect of dexamethasone on apoptosis induced by B. burgdorferi in primary rhesus DRG cultures. (A-C) show
representative images of sensory neurons in DRG cultures (red) staining with the neuronal marker NeuN, exposed to medium (A), live B.
burgdorferi at a MOI of 10:1 (B) and B. burgdorferi plus dexamethasone 15 μM (C), respectively after 24 hours of incubation. Apoptotic nuclei are
visualized in green as detected by the in situ TUNEL assay. The nuclei of all cells appear blue due to staining with the nuclear stain TOPRO3.
(D) shows percent apoptosis as measured by the in situ TUNEL assay and quantified by confocal microscopy after 24 hours of incubation of DRG
cultures exposed to medium or B. burgdorferi at a MOI of 10:1 in the presence and absence of dexamethasone (* P <0.05). Data represent percent
apoptosis mean values from DRG cells that were isolated from two adult rhesus macaques. Values for each animal were determined in duplicate.
Error bars represent standard deviations. DRG, dorsal root ganglia; MOI, multiplicity of infection; TUNEL, terminal deoxynucleotidyl transferase
mediated UTP nick end labeling.
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DRG cell cultures as well as the cultures of HSC stimu-
lated with live B. burgdorferi produced IL-6, IL-8 and
CCL2. Since we did not find IL-8 to be produced by
neurons in rhesus DRG explants, it is likely that satellite
glial cells contributed the IL-8 found in the DRG cell
culture supernatants.
These results support our hypothesis and show that
innate responses of neuronal and glial cells of the DRG
to B. burgdorferi mediate inflammation and that neur-
onal apoptosis occurs in this context. In agreement with
this notion we found that the anti-inflammatory drug
dexamethasone reduced both the levels of inflammatory
mediators and neuronal apoptosis as induced by B.
burgdorferi, suggesting that the two phenomena may be
causally related.
Cytokine/chemokine signaling and apoptosis are of
key importance in the regulation of neuroinflammatory
responses [43-47]. Since DRG axons project centrally
into the spinal cord and peripherally into the spinal
nerves, inflammation and cell death in the DRG elicited
by the Lyme disease spirochete could affect neuronal
survival and function both in the CNS and PNS. Further,
as the sensory neurons of the DRG play a key role in the
sensation of pain, inflammation in glial and neuronal
cells and cell death in the DRG could also modulate the
pain response [64]. Neurogenic pain secondary to radi-
culitis or inflammation of the dorsal roots is often the
earliest and sometimes only symptom in patients with
LNB [65]. It typically radiates from the spine into the ex-
tremities or trunk, and is described as ‘sharp or jabbing’
pain [16]. The immune mediators IL-6, IL-8 and CCL2
that we found to be elevated in the DRG cultures ex-
posed to live B. burgdorferi have been reported to play a
role in modulating inflammation and the pain response
[66-69]. IL-8 is known to induce expression of matrix
metalloproteinases, cell cycle and pro-apoptotic proteins,
and cell death in neurons [70]. IL-6 and CCL2 have been
reported to increase the sensitivity of sensory neurons to
pain [71-73].
The expression of the chemokine CCL2 and its recep-
tor (CCR2) is also up-regulated by DRG neurons in ro-
dent models of neuropathic pain [74]. Disruption of
CCL2 signaling has been shown to block the develop-
ment of neuropathic pain [75]. CCL2 is also known to
be involved in the signaling and upregulation of several
genes and proteins that participate in the signal trans-
duction of the pain response both in the DRG and in the
spinal cord [72,73]. This chemokine also functions as a
neuromodulator in DRG neurons [74]. We observed the
levels of CCL2 to be the highest among the immune me-
diators elicited by B. burgdorferi in both DRG cell and
HSC cultures. Similarly, we have reported high levels of
CCL2 in the CSF of rhesus macaques infected with B.
burgdorferi [20]. It is possible that CCL2 is a major
player in orchestrating inflammation as well as the pain
response in LNB.
The local application of IL-6 to the DRG of rats has been
shown to induce TNF-α and results in apoptosis of DRG
cells [76]. Earlier, we also reported the presence of IL-6 in
the sensory neurons of the DRG in rhesus macaques that
were inoculated intrathecally with B. burgdorferi [20].
Patients with LNB sometimes have persistent symptoms
such as fatigue, cognitive difficulties, depression and pain
even after appropriate antibiotic treatment. Because of the
Figure 6 Pro-inflammatory response induced by B. burgdorferi
in HSC cultures. The levels of immune mediators CCL2 (A), IL-6 (B)
and IL-8 (C) in HSC cultures exposed to live B. burgdorferi
spirochetes for 48 hours at a MOI of 10:1 and 50:1, respectively, and
in medium controls are shown (* P <0.05, ** P <0.01). Data represent
mean values and standard deviations between values of duplicate
wells that were seeded for each condition for each of the two
experiments set up using separate passage stocks. HSC, human
Schwann cells; MOI, multiplicity of infection.
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subjective nature of these complaints, many of these pa-
tients are believed to have a primary psychiatric diag-
nosis, such as depression or somatization disorder.
However, experiments such as those presented here
raise the possibility that some of these complaints may
be associated with inflammatory biochemical changes
in the CNS. Elevated levels of IL-6 can cause symptoms
of fatigue and malaise, common to many infectious
conditions, as well as Lyme disease [77]. Research in
other animal models of peripheral neuropathy has
demonstrated that peripheral inflammation alone can
trigger the brain cytokine system via afferent neural
pathways from the periphery to the CNS [78]. Similar
cascades of inflammation and apoptosis could also be
involved in the DRG in LNB. Ongoing cytokine activa-
tion in the nervous system could contribute to the
persistent symptoms of fatigue, pain and cognitive dys-
function that patients sometimes continue to experi-
ence despite having been treated for Lyme disease.
It is possible that B. burgdorferi, as well as the media-
tors elicited in cells of the DRG and Schwann cells that
we report here, could contribute to mediating inflamma-
tory and apoptotic signaling cascades in Schwann cells,
the myelinating cells of the PNS. This, in turn, may re-
sult in axonal degeneration [79].
The potential of Schwann cells to initiate the process
of Wallerian degeneration by releasing pro-inflammatory
cytokines that are involved in leukocyte recruitment and
differentiation (for example, IL-1β, CCL2, IL-8 and IL-6)
has been documented [80]. As we found the inflamma-
tory mediators IL-6, IL-8 and CCL2 in our HSC culture
supernatants stimulated with live B. burgdorferi, as well
as in the Schwann cells in the dorsal roots of the DRG
tissue explants incubated with live B. burgdorferi, it is
possible that similar mechanisms of inflammatory medi-
ated axonal damage could be contributing to the periph-
eral neuritis seen in LNB.
The high levels of CCL2 that we found to be elicited in
DRG neurons and satellite glial cells, as well as in Schwann
cells in response to B. burgdorferi, could trigger mecha-
nisms of demyelination in the PNS similar to those thought
to cause CNS demyelination in MS and experimental auto-
immune encephalomyelitis (EAE) [81,82]. CCR2, the recep-
tor of CCL2, has been documented to be involved in
macrophage recruitment to the injured PNS [83].
The ability of B. burgdorferi to activate the innate de-
fense mechanisms of the host [84] and particularly in cells
of the CNS is well documented [48,51,85-88]. It is possible
that similar signaling cascades could be involved in trigger-
ing the immune mechanisms that result in the pathogen-
esis of peripheral LNB. We propose that inflammation of
nerve roots and DRG and subsequent apoptosis in the
DRG could be early events that contribute to peripheral
neuropathy in Lyme neuroborreliosis.
Conclusions
In this model, B. burgdorferi induced an inflammatory
response and neuronal apoptosis of DRG. These patho-
physiological processes could contribute to peripheral
neuropathy in LNB.
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